Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors

Human Pathology

Volumn 41, Issue 12, 2010, Pages 1788-1793

  Dancer, Jane Y ^a   Henry, Stephen P ^a   Bondaruk, Jolanta ^a   Lee, Sangkyou ^a   Ayala, Alberto G ^b   De Crombrugghe, Benoit ^a   Czerniak, Bogdan ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Benign bone tumors; Master regulatory proteins; Skeletal development

Indexed keywords

TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DEVELOPMENT; CARTILAGE TUMOR; CHONDROBLASTOMA; CHONDROMYXOID FIBROMA; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OSTEOBLASTOMA; OSTEOID OSTEOMA; REGULATOR GENE; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CARTILAGE; CHILD; CHONDROBLASTOMA; CHONDROMA; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; FIBROMA; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; OSTEOBLASTOMA; OSTEOGENESIS; OSTEOMA, OSTEOID; SOX9 TRANSCRIPTION FACTOR; STEM CELLS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 78449297524     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.06.008     Document Type: Article

References (30)

1. Zou L., Zou X., and Li H. Molecular mechanism of osteochondroprogenitor fate determination during bone formation Adv Exp Med Biol 585 2006 431 441
2. Bi W., Deng J.M., and Zhang Z. Sox9 is required for cartilage formation Nat Genet 22 1999 85 89
3. Lefebvre V., Huang W., and Harley V.R. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene Mol Cell Biol 17 1997 2336 2346
4. Lefebvre V., Li P., and de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene Embo J 17 1998 5718 5733 (Pubitemid 28445983)
5. Komori T., Yagi H., and Nomura S. Requisite roles of Runx2 and Cbfb in skeletal development J Bone Miner Metab 21 2003 193 197
6. Hinoi E., Bialek P., and Chen Y.T. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium Genes Dev 20 2006 2937 2942
7. Nakashima K., Zhou X., and Kunkel G. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation Cell 108 2002 17 29
8. Nishio Y., Dong Y., and Paris M. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene Gene 372 2006 62 70
9. Koga T., Matsui Y., and Asagiri M. NFAT and Osterix cooperatively regulate bone formation Nat Med 11 2005 880 885
10. Akiyama H., Kim J.E., and Nakashima K. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors PNAS 102 2005 14665 14670
11. Nakashima K., and de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation Trends Gene 19 2003 458 466
12. Karsenty G. Transcriptional control of skeletogenesis Annu Rev Geonomics Hum Genet 9 2008 183 196
13. Kim J.H., Tuziak T., and Hu L. Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways Lab Invest 85 2005 532 549
14. Wada Y., Nishimura G., and Nagai T. Mutation analysis of SOX9 and single copy number variant analysis of the upstream region in eight patients with campomelic dysplasia and acampomelic campomelic dysplasia Am J Med Genet A 149A 2009 2882 2885
15. McDowall S., Argentaro A., and Ranganathan S. Functional and structural studies of wild type SOX9 and mutations causing campomelic dysplasia J Biol Chem 274 1999 24023 24030
16. Enomoto H., Shiojiri S., and Hoshi K. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene J Biol Chem 278 2003 23971 23977
17. Takeda S., Bonnamy J.P., and Owen M.J. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice Genes Dev 15 2001 467 481
18. Terry A., Kilbey A., and Vaillant F. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain Gene 336 2004 115 125
19. Baek W.Y., de Crombrugghe B., and Kim J.E. Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix J Bone Miner Res 24 2009 1055 1065
20. Wehrli B.M., Huang W., and De Crombrugghe B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors Hum Pathol 34 2003 263 269
21. Konishi E., Nakashima Y., and Iwasa Y. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone Hum Pathol 41 2010 208 213
22. Park H.R., and Park Y.K. Differential expression of runx2 and Indian hedgehog in cartilaginous tumors Pathol Oncol Res 13 2007 32 37
23. Lian J.B., Stein G.S., and Javed A. Networks and hubs for the transcriptional control of osteoblastogenesis Rev Endocr Metab Disord 7 2006 1 16
24. Kawakami T., Shimizu T., and Kimura A. Immunohistochemical examination of cytological differentiation in osteosarcomas Eur J Med Res 10 2005 475 479
25. Eliseev R.A., Dong Y.F., and Sampson E. Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis Oncogene 27 2008 3605 3614
26. Won K.Y., Park H.R., and Park Y.K. Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma Tumori 95 2009 311 316
27. Thomas D.M., Johnson S.A., and Sims N.A. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma J Cell Biol 167 2004 925 934
28. Cao Y., Zhou Z., and de Crombrugghe B. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma Cancer Res 65 2005 1124 1128
29. Cao Y., Jia S.F., and Chakravarty G. The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells Mol Cancer Res 6 2008 119 126
30. Dorfman H, Czerniak B. Bone tumors, textbook of skeletal pathology. Mosby-Year Book, Inc: Philadelphia, AP 1999. Chapter 4: benign osteoblastic tumors.